Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Therapeutic depletion of monocyte-derived cells protects from long-term axonal loss in experimental autoimmune encephalomyelitis.
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis.
Human myelin proteome and comparative analysis with mouse myelin.
A white matter lesion-filling approach to improve brain tissue volume measurements.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
Clinical and demographical characteristics of primary progressive multiple sclerosis in Isfahan, Iran.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Relevance of endoglin, IL-1α, IL-1β and anti-ovarian antibodies in females with multiple sclerosis.
Increased expression ratio of matrix metalloproteinase-9 (MMP9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) RNA levels in Iranian multiple sclerosis patients.
X-ray radiation and the risk of multiple sclerosis: Do the site and dose of exposure matter?
Serum and CSF GQ1b antibodies in isolated ophthalmologic syndromes.
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease.
Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Levodopa-responsive Holmes' Tremor Caused by a Single Inflammatory Demyelinating Lesion.
[Pathology, diagnosis, and treatment of combined central and peripheral demyelination].
Pages
« first
‹ previous
…
679
680
681
682
683
684
685
686
687
…
next ›
last »